More accurate exchange rates & forex converters are available at ExchangeRates.me


« Crude prices drop 5.4% for the day, up slightly for the week
SEC says in preliminary ARS settlement with Merrill »

FDA approves Amgen’s Nplate

BOSTON (MarketWatch) — The Food and Drug Administration said it has approved Amgen Inc.’s new hematology product Nplate for the treatment of the condition chronic immune thrombocytopenic purpura, a rare blood disorder that can lead to serious bleeding. Nplate, also known as romiplostim, is used to stimulate bone marrow to produce additional platelets to help in clotting.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Original post by Forextvblog

This entry was posted on Friday, August 22nd, 2008 at 1:24 pm and is filed under Daily Forex Analysis. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.